AWK vs DMAAR · P/E 22, rev $4.65B vs $1.8M cap
American Water Works (AWK) versus Drugs Made In America Acquisition Corp. Rights (DMAAR) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
DMAAR does not have a complete income-statement cache yet.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. DMAAR currently screens at market cap $1.8M.
Not investment advice. Open the AWK and DMAAR stock pages for the full models.
Not investment advice.